US Stock MarketDetailed Quotes
BSPM Biostar Pharmaceuticals
- 0.000100
- 0.0000000.00%
15min DelayClose Nov 26 16:00 ET
263.72Market Cap0.00P/E (TTM)
0.000000High0.000000Low0Volume0.000000Open0.000100Pre Close0.00Turnover0.00%Turnover Ratio0.00P/E (Static)2.64MShares0.00950052wk High0.00P/B221.02Float Cap0.00000152wk Low--Dividend TTM2.21MShs Float1.880000Historical High--Div YieldTTM0.00%Amplitude0.000001Historical Low--Avg Price1Lot Size
Biostar Pharmaceuticals Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2017 | (Q2)Jun 30, 2017 | (Q1)Mar 31, 2017 | (FY)Dec 31, 2016 | (Q4)Dec 31, 2016 | (Q3)Sep 30, 2016 | (Q2)Jun 30, 2016 | (Q1)Mar 31, 2016 | (FY)Dec 31, 2015 | (Q4)Dec 31, 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | -91.21%2.38M | -82.71%317.79K | -84.67%644.93K | -95.63%620.14K | -88.40%801.63K | -55.83%27.13M | -87.22%1.84M |
| Operating revenue | --0 | --0 | --0 | -91.21%2.38M | -82.71%317.79K | -84.67%644.93K | -95.63%620.14K | -88.40%801.63K | -55.83%27.13M | -87.22%1.84M |
| Cost of revenue | 0 | 0 | 0 | -90.83%1.47M | -66.87%354.54K | -90.06%336.87K | -96.10%321.25K | -86.28%456.66K | -48.54%16.03M | -85.93%1.07M |
| Gross profit | 0 | 0 | 0 | -91.76%915.17K | -104.78%-36.75K | -62.25%308.06K | -94.97%298.89K | -90.37%344.97K | -63.32%11.1M | -88.67%768.03K |
| Operating expense | -74.74%573.38K | -78.66%1.53M | -2.68%986.3K | -79.62%4.48M | -174.77%-5.96M | -9.82%2.27M | 2.10%7.16M | -77.33%1.01M | -24.15%21.98M | 6.27%7.98M |
| Selling and administrative expenses | -26.40%573.38K | 84.22%1.53M | 2.60%1.04M | -72.90%3.6M | -58.01%978.85K | -48.69%779.06K | -86.14%829.48K | -70.65%1.01M | -49.29%13.29M | -65.78%2.33M |
| -Selling and marketing expense | -94.96%14.67K | -95.79%12.21K | -15.35%273.48K | -86.46%1.17M | -25.21%265.38K | -65.18%290.92K | -93.96%290.05K | -87.93%323.07K | -53.27%8.64M | -93.50%354.82K |
| -General and administrative expense | 14.46%558.71K | 181.00%1.52M | 10.99%766.33K | -47.70%2.43M | -63.90%713.47K | -28.53%488.14K | -54.43%539.43K | -11.00%690.42K | -39.77%4.65M | 45.58%1.98M |
| Research and development costs | ---- | ---- | ---- | -71.55%1.14M | ---- | ---- | ---- | ---- | 45.36%4.02M | 41.33%977.37K |
| Provision for doubtful accounts | --0 | --0 | ---53.5K | -105.69%-265.49K | ---8.09M | --1.49M | --6.33M | --0 | --4.67M | ---- |
| Operating profit | 70.78%-573.38K | 77.73%-1.53M | -47.54%-986.3K | 67.22%-3.56M | 182.23%5.93M | -15.34%-1.96M | -539.25%-6.86M | 24.89%-668.52K | -933.04%-10.87M | -892.81%-7.21M |
| Net non-operating interest income expense | 55.22%-47.2K | -60,297.37%-45.9K | -16.15%-44.41K | 25.36%-205.03K | 94.75%-61.31K | -133.83%-105.4K | -100.02%-76 | -114.66%-38.24K | -123.36%-274.7K | -642.16%-1.17M |
| Non-operating interest income | --13 | --3 | --1.3K | -86.90%1.17K | 100.12%1.17K | --0 | --0 | --0 | -99.33%8.9K | -429.58%-945.7K |
| Non-operating interest expense | -55.21%47.21K | 60,301.32%45.91K | 19.56%45.72K | -27.29%206.2K | -71.77%62.48K | --105.4K | -94.56%76 | -37.78%38.24K | 83.50%283.6K | 208.69%221.31K |
| Other net income (expense) | -1.66%495.39K | 1,506.52%259.55K | -41.24%16.57K | 105.72%723.96K | 101.37%175.88K | 247.98%503.73K | -82.52%16.16K | 385.71%28.19K | -1,236.52%-12.65M | -5,587.63%-12.87M |
| Gain on sale of security | 500.88%12.93K | 1,505.84%259.44K | -39.82%16.97K | -29.93%227.11K | 81.64%180.61K | -98.51%2.15K | -82.11%16.16K | 385.71%28.19K | -43.89%324.09K | -57.88%99.43K |
| Special income (charges) | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | -745.60%-12.89M | ---- |
| -Less:Impairment of capital assets | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | 13.60%2.97M | ---- |
| -Write off | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --9.91M | ---- |
| Other non- operating income (expenses) | -3.81%482.47K | --110 | ---401 | 687.69%496.86K | 94.55%-4.72K | 91,764.10%501.58K | ---- | ---- | -126,285.07%-84.54K | -1,695.01%-86.61K |
| Income before tax | 91.99%-125.19K | 80.80%-1.31M | -49.45%-1.01M | 87.20%-3.05M | 128.43%6.04M | -25.63%-1.56M | -934.65%-6.84M | -6.20%-678.57K | -1,650.39%-23.79M | -2,782.77%-21.25M |
| Income tax | 0 | 0 | 0 | 101.01%2.65M | 35.52%2.65M | 0 | 134.44%58.23K | 87.84%-58.23K | 139.83%1.32M | 157.69%1.96M |
| Net income | 91.99%-125.19K | 80.96%-1.31M | -63.48%-1.01M | 77.31%-5.7M | 114.60%3.39M | -24.62%-1.56M | -1,301.72%-6.9M | -287.46%-620.34K | -617.98%-25.11M | -973.53%-23.21M |
| Net income continuous Operations | 91.99%-125.19K | 80.96%-1.31M | -63.48%-1.01M | 77.31%-5.7M | 114.60%3.39M | -24.62%-1.56M | -1,301.72%-6.9M | -287.46%-620.34K | -617.98%-25.11M | -973.53%-23.21M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | 91.99%-125.19K | 80.96%-1.31M | -63.48%-1.01M | 77.31%-5.7M | 114.60%3.39M | -24.62%-1.56M | -1,301.72%-6.9M | -287.46%-620.34K | -617.98%-25.11M | -973.53%-23.21M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | 91.99%-125.19K | 80.96%-1.31M | -63.48%-1.01M | 77.31%-5.7M | 114.60%3.39M | -24.62%-1.56M | -1,301.72%-6.9M | -287.46%-620.34K | -617.98%-25.11M | -973.53%-23.21M |
| Basic earnings per share | 92.96%-0.05 | 83.97%-0.5 | -35.71%-0.38 | 78.07%-2.5 | 115.28%1.61 | -24.56%-0.71 | -1,318.18%-3.12 | -300.00%-0.28 | -595.65%-11.4 | -943.20%-10.54 |
| Diluted earnings per share | 92.96%-0.05 | 83.97%-0.5 | -35.71%-0.38 | 78.07%-2.5 | 115.28%1.61 | -24.56%-0.71 | -1,318.18%-3.12 | -300.00%-0.28 | -595.65%-11.4 | -943.20%-10.54 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
